Planet Labs PBC Quarterly Cash Flow Statements Chart
Quarterly
|
Annual
Planet Labs PBC Quarterly Cash Flow Statements Table
Quarterly
|
Annual
Unit: USD | 2025-07-31 | 2025-04-30 | 2025-01-31 | 2024-10-31 | 2024-07-31 | 2024-04-30 | 2024-01-31 | 2023-10-31 | 2023-07-31 | 2023-04-30 | 2023-01-31 | 2022-10-31 | 2022-07-31 | 2022-04-30 | 2022-01-31 | 2021-09-30 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
operating activities | ||||||||||||||||
net income | -22,592,000 | -12,628,000 | -35,154,000 | -20,081,000 | -38,668,000 | -29,293,000 | -30,086,000 | -38,004,000 | -37,975,000 | -34,444,000 | -37,841,000 | -40,236,000 | -39,529,000 | -44,360,000 | -115,702,485 | -6,635,827 |
adjustments to reconcile net income to net cash from operating activities | ||||||||||||||||
depreciation and amortization | 10,622,000 | 11,082,000 | 9,272,000 | 10,117,000 | 13,145,000 | 13,103,000 | 11,606,000 | 13,625,000 | 12,160,000 | 10,248,000 | 9,333,000 | 10,784,000 | 11,588,000 | 11,625,000 | ||
stock-based compensation, net of capitalized cost of 1,318 and 1,292, respectively | ||||||||||||||||
change in fair value of warrant liabilities | 5,679,000 | -10,387,000 | 16,242,000 | -198,000 | 602,000 | -1,530,000 | -6,833,000 | -1,226,000 | -5,945,000 | |||||||
change in fair value of contingent consideration | 717,000 | -41,000 | 276,000 | 1,237,000 | 2,025,000 | -101,000 | 182,000 | -396,000 | -104,000 | -423,000 | ||||||
other | 309,000 | 1,229,000 | 12,000 | 343,000 | -728,000 | -547,000 | -783,000 | -791,000 | -1,113,000 | -1,634,000 | -464,000 | -27,000 | 67,000 | 476,000 | ||
changes in operating assets and liabilities | ||||||||||||||||
accounts receivable | 23,548,000 | -21,185,000 | -17,471,000 | 5,455,000 | -5,450,000 | 5,482,000 | 1,214,000 | -2,284,000 | -1,467,000 | -121,000 | -8,924,000 | -3,358,000 | -1,387,000 | 19,982,000 | ||
prepaid expenses and other assets | -982,000 | 1,254,000 | -133,000 | 7,221,000 | 2,009,000 | -731,000 | 1,015,000 | 4,331,000 | 2,382,000 | 2,770,000 | -608,000 | -5,040,000 | -4,029,000 | -403,000 | ||
accounts payable, accrued and other liabilities | 4,573,000 | -8,915,000 | -5,606,000 | -11,815,000 | 9,321,000 | -5,237,000 | -4,308,000 | -3,542,000 | -6,451,000 | -10,713,000 | 5,663,000 | -6,783,000 | 1,846,000 | -3,712,000 | ||
deferred revenue | 33,741,000 | 42,072,000 | 15,501,000 | 1,220,000 | -428,000 | -721,000 | 2,680,000 | -400,000 | 27,722,000 | -7,765,000 | 4,995,000 | -4,217,000 | -8,218,000 | -6,947,000 | ||
deferred hosting costs | -1,297,000 | 2,323,000 | -1,252,000 | -1,252,000 | -1,252,000 | 2,206,000 | -1,173,000 | -1,174,000 | -988,000 | 2,070,000 | -992,000 | -991,000 | -991,000 | 231,000 | ||
net cash from operating activities | 67,774,000 | 17,346,000 | -6,295,000 | 4,076,000 | -7,858,000 | -4,297,000 | -6,837,000 | -22,870,000 | 9,597,000 | -30,601,000 | -14,815,000 | -30,314,000 | -22,270,000 | -6,534,000 | -38,748,739 | -245,436 |
capex | -21,486,000 | -9,344,000 | -12,780,000 | -8,862,000 | -16,621,000 | -11,356,000 | -10,058,000 | -8,645,000 | -16,632,000 | -7,075,000 | -2,015,000 | -2,965,000 | -4,274,000 | -3,506,000 | 0 | 0 |
free cash flows | 46,288,000 | 8,002,000 | -19,075,000 | -4,786,000 | -24,479,000 | -15,653,000 | -16,895,000 | -31,515,000 | -7,035,000 | -37,676,000 | -16,830,000 | -33,279,000 | -26,544,000 | -10,040,000 | -38,748,739 | -245,436 |
investing activities | ||||||||||||||||
purchases of property and equipment | -20,291,000 | -8,119,000 | -11,603,000 | -7,633,000 | -15,123,000 | -9,938,000 | -8,905,000 | -7,377,000 | -15,373,000 | -6,336,000 | -1,432,000 | -2,499,000 | -3,648,000 | -2,861,000 | ||
capitalized internal-use software | -1,195,000 | -1,225,000 | -1,177,000 | -1,229,000 | -1,498,000 | -1,418,000 | -1,153,000 | -1,268,000 | -1,259,000 | -739,000 | -583,000 | -466,000 | -626,000 | -645,000 | ||
maturities of available-for-sale securities | 16,008,000 | 11,123,000 | 4,350,000 | 10,238,000 | 14,650,000 | 32,158,000 | 18,414,000 | 36,141,000 | 76,762,000 | 30,000,000 | 42,172,000 | |||||
sales of available-for-sale securities | 8,672,000 | 582,000 | 30,181,000 | 12,130,000 | 107,095,000 | 43,116,000 | 5,508,000 | 39,082,000 | ||||||||
purchases of available-for-sale securities | -34,658,000 | -23,926,000 | -53,613,000 | -28,043,000 | -22,973,000 | -38,466,000 | -92,474,000 | -35,229,000 | -40,976,000 | -44,208,000 | ||||||
business acquisition, net of cash acquired | 0 | 0 | 0 | -1,068,000 | ||||||||||||
purchases of licensed imagery intangible assets | -271,000 | -621,000 | -227,000 | -266,000 | ||||||||||||
net cash from investing activities | -19,438,000 | 1,740,000 | -13,134,000 | -10,686,000 | 51,243,000 | 30,483,000 | -9,554,000 | 20,270,000 | -31,721,000 | -12,581,000 | -4,785,000 | -34,292,000 | -199,534,000 | -3,652,000 | 319,851,000 | 0 |
financing activities | ||||||||||||||||
proceeds from the exercise of common stock options | 5,489,000 | 2,962,000 | 4,043,000 | 32,000 | 280,000 | 20,000 | 618,000 | 412,000 | 3,063,000 | 3,295,000 | 3,792,000 | 4,491,000 | 1,455,000 | 4,963,000 | ||
payments for withholding taxes related to the net share settlement of equity awards | -7,172,000 | -5,264,000 | -4,610,000 | |||||||||||||
proceeds from employee stock purchase program | 817,000 | 346,000 | 466,000 | |||||||||||||
payments of contingent consideration for business acquisitions | 0 | -4,820,000 | 0 | -7,500,000 | ||||||||||||
net cash from financing activities | -1,004,000 | -9,159,000 | -233,000 | -10,196,000 | -2,731,000 | -2,375,000 | -1,241,000 | -1,947,000 | 191,000 | 1,399,000 | 1,483,000 | 2,327,000 | -502,000 | 4,552,000 | 140,645,764 | 92,001 |
effect of exchange rate changes on cash and cash equivalents, and restricted cash and cash equivalents | -6,000 | 5,683,000 | -275,000 | 108,000 | 242,000 | -276,000 | 82,000 | -220,000 | -22,000 | 177,000 | ||||||
net increase in cash and cash equivalents, and restricted cash and cash equivalents | 47,326,000 | 15,610,000 | -19,937,000 | -16,698,000 | 40,896,000 | 23,535,000 | ||||||||||
cash and cash equivalents, and restricted cash and cash equivalents at the beginning of the period | 0 | 129,994,000 | 0 | 0 | 0 | 102,198,000 | 0 | 0 | 0 | 188,076,000 | ||||||
cash and cash equivalents, and restricted cash and cash equivalents at the end of the period | 47,326,000 | 145,604,000 | -19,937,000 | -16,698,000 | 40,896,000 | 125,733,000 | -17,550,000 | -4,767,000 | -21,955,000 | 146,470,000 | ||||||
stock-based compensation, net of capitalized cost of 673 and 673, respectively | 12,542,000 | |||||||||||||||
stock-based compensation, net of capitalized cost of 2,339, 2,344 and 1,329, respectively | ||||||||||||||||
stock-based compensation, net of capitalized cost of 1,793 and 1,851, respectively | ||||||||||||||||
stock-based compensation, net of capitalized cost of 1,292 and 1,408, respectively | ||||||||||||||||
shares repurchased for tax withholdings on vesting of restricted stock units | ||||||||||||||||
proceeds from employee stock purchase plan | ||||||||||||||||
stock-based compensation, net of capitalized cost of 673 and 627, respectively | 13,072,000 | |||||||||||||||
purchases of licensed imagery | -4,024,000 | |||||||||||||||
class a common stock withheld to satisfy employee tax withholding obligations | -2,015,000 | -1,859,000 | -2,359,000 | -2,857,000 | -1,896,000 | -2,009,000 | -2,164,000 | -1,753,000 | -411,000 | |||||||
stock-based compensation, net of capitalized cost of 2,344, 1,329 and 1,229, respectively | ||||||||||||||||
change in fair value of convertible notes and warrant liabilities | -1,185,000 | 19,000 | -2,112,000 | -3,276,000 | ||||||||||||
debt extinguishment loss | ||||||||||||||||
amortization of debt discount and issuance costs | ||||||||||||||||
impairment of capitalized internal-use software | ||||||||||||||||
deferred rent | ||||||||||||||||
proceeds from the early exercise of common stock options | ||||||||||||||||
proceeds from business combination and pipe investment, net of transaction costs | ||||||||||||||||
principal payment of debt | ||||||||||||||||
stock-based compensation, net of capitalized cost of 1,851 and 1,261, respectively | ||||||||||||||||
business acquisition | ||||||||||||||||
payment of transaction costs related to the business combination | 0 | |||||||||||||||
net decrease in cash and cash equivalents, and restricted cash and cash equivalents | -4,767,000 | -21,955,000 | -41,606,000 | |||||||||||||
stock-based compensation, net of capitalized cost of 1,408 and 889, respectively | ||||||||||||||||
stock-based compensation, net of capitalized cost of 627 and 437, respectively | 15,356,000 | |||||||||||||||
stock-based compensation, net of capitalized cost of 1,329, 1,229 and 526, respectively | ||||||||||||||||
debt extinguishment (gain) loss | ||||||||||||||||
deferred income taxes | -495,000 | 97,000 | -86,000 | 28,000 | ||||||||||||
proceeds from issuance of debt and common stock warrants, net of issuance costs | ||||||||||||||||
principal payment of convertible notes | ||||||||||||||||
proceeds from issuance of convertible notes and preferred stock warrant | ||||||||||||||||
stock-based compensation, net of capitalized cost of 1,261 and 514, respectively | ||||||||||||||||
effect of exchange rate changes on cash, cash equivalents and restricted cash | -663,000 | -469,000 | -649,000 | |||||||||||||
net decrease in cash, cash equivalents and restricted cash | ||||||||||||||||
cash, cash equivalents and restricted cash at the beginning of the period | 0 | 0 | 496,814,000 | |||||||||||||
cash, cash equivalents and restricted cash at the end of the period | -62,942,000 | -222,775,000 | 490,531,000 | |||||||||||||
stock-based compensation, net of capitalized cost of 889 and 333, respectively | ||||||||||||||||
net increase in cash, cash equivalents and restricted cash | -222,775,000 | -6,283,000 | ||||||||||||||
stock-based compensation, net of capitalized cost of 437 and 141, respectively | 19,822,000 | |||||||||||||||
stock-based compensation, net of capitalized cost of 1,229, 526 and 957, respectively | ||||||||||||||||
benefit from doubtful accounts | ||||||||||||||||
proceeds from issuance of convertible preferred stock | ||||||||||||||||
cash flows from operating activities: | ||||||||||||||||
adjustments to reconcile net income to net cash from operating activities: | ||||||||||||||||
general and administrative expenses paid by related party under promissory note | 0 | |||||||||||||||
income from investments held in trust account | ||||||||||||||||
loss upon issuance of private placement warrants | 0 | |||||||||||||||
offering costs associated with derivative warrant liabilities | 0 | |||||||||||||||
change in fair value of derivative warrant liabilities | 2,718,668 | |||||||||||||||
legal expenses deferred until business combination | ||||||||||||||||
changes in operating assets and liabilities: | ||||||||||||||||
prepaid expenses | 118,335 | |||||||||||||||
accounts payable | 20,833 | |||||||||||||||
accrued expenses | 3,523,302 | |||||||||||||||
franchise tax payable | 50,000 | |||||||||||||||
cash flows from investing activities | ||||||||||||||||
cash deposited in trust account | 0 | |||||||||||||||
cash flows from financing activities: | ||||||||||||||||
proceeds from loans from related parties | 237,286 | |||||||||||||||
repayment of loans from related parties | -125,286 | |||||||||||||||
proceeds received from initial public offering, gross | 0 | |||||||||||||||
proceeds received from private placement | 0 | |||||||||||||||
offering costs paid | -20,000 | |||||||||||||||
net increase in cash | -153,435 | |||||||||||||||
cash - beginning of the period | ||||||||||||||||
cash - end of the period | ||||||||||||||||
supplemental disclosure of noncash activities: | ||||||||||||||||
offering costs included in accounts payable | 0 | |||||||||||||||
offering costs included in accrued expenses | -20,000 | |||||||||||||||
offering costs paid by related party under promissory note | 0 | |||||||||||||||
prepaid expenses paid by related party under promissory note | 0 | |||||||||||||||
reversal of accrued expenses | 0 | |||||||||||||||
deferred underwriting commissions in connection with the initial public offering | 0 | |||||||||||||||
deferred legal fees | 1 | |||||||||||||||
• | ||||||||||||||||
gain on investments (net), dividends and interest, held in trust account | ||||||||||||||||
cash—beginning of the period | ||||||||||||||||
cash—end of the period | ||||||||||||||||
value of class a common stock subject to possible redemption |
We provide you with 20 years of cash flow statements for Planet Labs PBC stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as operating cash flows, cash levels, capital expenditures, profits, stock-based compensations and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Planet Labs PBC stock. Explore the full financial landscape of Planet Labs PBC stock with our expertly curated income statements.
The information provided in this report about Planet Labs PBC stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.